Results
1 -
10 of
10Topoisomerase I Inhibitors: Chemical Biology, DNA Topoisomerases and Cancer Antitumor activity of edotecarin in breast carcinoma models, Cancer Chemotherapy and Pharmacology A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors, Cancer Chemotherapy and Pharmacology Phase I and pharmacokinetic study of edotecarin, a novel topoisomerase I inhibitor, administered once every 3??weeks in patients with solid tumors, Cancer Chemotherapy and Pharmacology Therapeutic activity of the topoisomerase I inhibitor J-107088 [6-N-(1-hydroxymethyla-2-hydroxy) ethylamino-12,13-dihydro-13-(??-D-gluco pyranosyl)-5H-indolo[2,3-a]-pyrrolo[3,4-c]-carbazole-5,7(6H)-dione] against pediatric and adult central nervous system tumor xenografts, Cancer Chemotherapy and Pharmacology Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells, Cancer Chemotherapy and Pharmacology An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma, Journal of Neuro-Oncology Topoisomerase i targeting agents in small-cell lung cancer, Current Oncology Reports Identification of Leishmania donovani Topoisomerase 1 inhibitors via intuitive scaffold hopping and bioisosteric modification of known Top 1 inhibitors, Scientific Reports